Targeting myofibroblastic cancer-associated fibroblasts (myCAFs): a promising strategy for overcoming tumor progression and immunotherapy resistance
Vis Cancer Med, 6 (2025) 4
Published online: 17 March 2025
DOI: 10.1051/vcm/2025005